
According to Benzinga Pro, during Q1, NuVasive (NASDAQ:NUVA) earned $19.20 million, a 152.27% increase from the preceding quarter. NuVasive's sales decreased to $290.76 million, a 3.75% change since Q4. In Q4, NuVasive brought in $302.07 million in sales but lost $36.74 million in earnings.